INM vs NVST · rev $4.9M vs P/E 56, rev $1.44B
InMed Pharmaceuticals Inc (INM) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
INM currently screens at market cap $5.2M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the INM and NVST stock pages for the full models.
Not investment advice.